The DOI matches its Crossref record; 44 of the 44 references it cites were found in a registry or an index.
Glucocorticoid-induced skeletal muscle atrophy is associated with upregulation of myostatin gene expression
Abstract
The mechanisms by which excessive glucocorticoids cause muscular atrophy remain unclear. We previously demonstrated that dexamethasone increases the expression of myostatin, a negative regulator of skeletal muscle mass, in vitro. In the present study, we tested the hypothesis that dexamethasone-induced muscle loss is associated with increased myostatin expression in vivo. Daily administration (60, 600, 1,200 μg/kg body wt) of dexamethasone for 5 days resulted in rapid, dose-dependent loss of body weight (-4.0, -13.4, -17.2%, respectively, P < 0.05 for each comparison), and muscle atrophy (6.3, 15.0, 16.6% below controls, respectively). These changes were associated with dose-dependent, marked induction of intramuscular myostatin mRNA (66.3, 450, 527.6% increase above controls, P < 0.05 for each comparison) and protein expression (0.0, 260.5, 318.4% increase above controls, P < 0.05). We found that the effect of dexamethasone on body weight and muscle loss and upregulation of intramuscular myostatin expression was time dependent. When dexamethasone treatment (600 μg · kg-1 · day-1) was extended from 5 to 10 days, the rate of body weight loss was markedly reduced to ∼2% within this extended period. The concentrations of intramuscular myosin heavy chain type II in dexamethasone-treated rats were significantly lower (-43% after 5-day treatment, -14% after 10-day treatment) than their respective corresponding controls. The intramuscular myostatin concentration in rats treated with dexamethasone for 10 days returned to basal level. Concurrent treatment with RU-486 blocked dexamethasone-induced myostatin expression and significantly attenuated body loss and muscle atrophy. We propose that dexamethasone-induced muscle loss is mediated, at least in part, by the upregulation of myostatin expression through a glucocorticoid receptor-mediated pathway.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Double muscling in cattle due to mutations in the myostatin gene
McPherron, A. C., & Lee, S.-J. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.23.12457 · Cited by 2,039
Regulation of myostatin activity and muscle growth
Lee, S.-J., & McPherron, A. C. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.151270098 · Cited by 1,616
A deletion in the bovine myostatin gene causes the double–muscled phenotype in cattle
Grobet, L., Royo Martin, L. J., Poncelet, D., Pirottin, D., Brouwers, B., Riquet, J., Schoeberlein, A., Dunner, S., Ménissier, F., Massabanda, J., et al. (1997) · Nature Genetics · doi:10.1038/ng0997-71 · Cited by 1,556
Mutations in myostatin ( GDF8 ) in Double-Muscled Belgian Blue and Piedmontese Cattle
Kambadur, R., Sharma, M., Smith, T. P. L., & Bass, J. J. (1997) · Genome Research · doi:10.1101/gr.7.9.910 · Cited by 1,204
Mechanisms of Muscle Wasting — The Role of the Ubiquitin–Proteasome Pathway
Mitch, W. E., & Goldberg, A. L. (1996) · New England Journal of Medicine · doi:10.1056/nejm199612193352507 · Cited by 1,166
Myostatin, a Negative Regulator of Muscle Growth, Functions by Inhibiting Myoblast Proliferation
Thomas, M., Langley, B., Berry, C., Sharma, M., Kirk, S., Bass, J., & Kambadur, R. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m004356200 · Cited by 1,014
Electrophoretic separation of rat skeletal muscle myosin heavy-chain isoforms
Talmadge, R. J., & Roy, R. R. (1993) · Journal of Applied Physiology · doi:10.1152/jappl.1993.75.5.2337 · Cited by 803
Gonzalez-Cadavid, N. F., Taylor, W. E., Yarasheski, K., Sinha-Hikim, I., Ma, K., Ezzat, S., Shen, R., Lalani, R., Asa, S., Mamita, M., et al. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.25.14938 · Cited by 571
Self-citationControl of muscle development by dueling HATs and HDACs
McKinsey, T. A., Zhang, C. L., & Olson, E. N. (2001) · Current Opinion in Genetics & Development · doi:10.1016/s0959-437x(00)00224-0 · Cited by 414
Myostatin inhibits cell proliferation and protein synthesis in C2C12 muscle cells
Taylor, W. E., Bhasin, S., Artaza, J., Byhower, F., Azam, M., Willard, D. H., Kull, F. C., & Gonzalez-Cadavid, N. (2001) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.2001.280.2.e221 · Cited by 410
Self-citationCarlson, C. J., Booth, F. W., & Gordon, S. E. (1999) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.1999.277.2.r601 · Cited by 357
Myostatin is an inhibitor of myogenic differentiation
Rı́os, R., Carneiro, I., Arce, V. M., & Devesa, J. (2002) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00372.2001 · Cited by 323
Transcription factors and asthma
Barnes, P., & Adcock, I. (1998) · European Respiratory Journal · doi:10.1183/09031936.98.12010221 · Cited by 320
Glucocorticoids and muscle catabolism
Hasselgren, P.-O. (1999) · Current Opinion in Clinical Nutrition and Metabolic Care · doi:10.1097/00075197-199905000-00002 · Cited by 295
Myostatin and the control of skeletal muscle mass
Lee, S.-J., & McPherron, A. C. (1999) · Current Opinion in Genetics & Development · doi:10.1016/s0959-437x(99)00004-0 · Cited by 273
Energy-ubiquitin-dependent muscle proteolysis during sepsis in rats is regulated by glucocorticoids.
Tiao, G., Fagan, J., Roegner, V, Lieberman, M., Wang, J. J., Fischer, J. E., & Hasselgren, P. O. (1996) · Journal of Clinical Investigation · doi:10.1172/jci118421 · Cited by 249
Modulation of myostatin expression during modified muscle use
WEHLING, M., CAI, B., & TIDBALL, J. G. (2000) · The FASEB Journal · doi:10.1096/fasebj.14.1.103 · Cited by 229
Ma, K., Mallidis, C., Artaza, J., Taylor, W., Gonzalez-Cadavid, N., & Bhasin, S. (2001) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.2001.281.6.e1128 · Cited by 208
Self-citationEndocrine regulation of protein breakdown in skeletal muscle
Kettelhut, I. C., Wing, S. S., & Goldberg, A. L. (1988) · Diabetes/Metabolism Reviews · doi:10.1002/dmr.5610040805 · Cited by 200
Odedra, B. R., Bates, P. C., & Millward, D. J. (1983) · Biochemical Journal · doi:10.1042/bj2140617 · Cited by 197
Myostatin Regulates Cell Survival during C2C12 Myogenesis
Ríos, R., Carneiro, I., Arce, V. M., & Devesa, J. (2001) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.2000.4159 · Cited by 189
Lalani, R., Bhasin, S., Byhower, F., Tarnuzzer, R., Grant, M., Shen, R., Asa, S., Ezzat, S., & Gonzalez-Cadavid, N. (2000) · Journal of Endocrinology · doi:10.1677/joe.0.1670417 · Cited by 177
Self-citationDardevet, D., Sornet, C., Taillandier, D., Savary, I., Attaix, D., & Grizard, J. (1995) · Journal of Clinical Investigation · doi:10.1172/jci118264 · Cited by 174
Activation of the ubiquitin pathway in rat skeletal muscle by catabolic doses of glucocorticoids
Auclair, D., Garrel, D. R., Chaouki Zerouala, A., & Ferland, L. H. (1997) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.1997.272.3.c1007 · Cited by 161
Molecular regulation of muscle cachexia: it may be more than the proteasome.
Hasselgren, P.-O., Wray, C., & Mammen, J. (2002) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.2001.5849 · Cited by 146
Artaza, J. N., Bhasin, S., Mallidis, C., Taylor, W. E., Ma, K., & González-Cadavid, N. F. (2002) · Journal of Cellular Physiology · doi:10.1002/jcp.10044 · Cited by 129
Self-citationA missense mutant myostatin causes hyperplasia without hypertrophy in the mouse muscle
Nishi, M., Yasue, A., Nishimatu, S., Nohno, T., Yamaoka, T., Itakura, M., Moriyama, K., Ohuchi, H., & Noji, S. (2002) · Biochemical and Biophysical Research Communications · doi:10.1016/s0006-291x(02)00209-7 · Cited by 111
Regulation of Myostatin by Glucocorticoids After Thermal Injury
Lang, C. H., Silvis, C., Nystrom, G. J., & Frost, R. A. (2001) · The FASEB Journal · doi:10.1096/fj.00-0849fje · Cited by 105
Tiao, G. M., Lieberman, M. A., Fischer, J. E., & Hasselgren, P.-O. (1997) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.1997.272.3.r849 · Cited by 96
C/EBP DNA-binding activity is upregulated by a glucocorticoid-dependent mechanism in septic muscle
Penner, G. C., Gang, G., Sun, X., Wray, C. J., & Hasselgren, P. (2002) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00512.2001 · Cited by 88
Effect of glucocorticoid excess on skeletal muscle and heart protein synthesis in adult and old rats
Savary‐Auzeloux, I., Debras, E., Dardevet, D. P., Sornet, C., Capitan, P., Prugnaud, J., Mirand, P. P., & Grizard, J. (1998) · British Journal Of Nutrition · doi:10.1079/bjn19980047 · Cited by 86
Marinovic, A. C., Zheng, B., Mitch, W. E., & Price, S. R. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m200501200 · Cited by 85
Konagaya, M., Bernard, P. A., & Max, S. R. (1986) · Endocrinology · doi:10.1210/endo-119-1-375 · Cited by 80
Glucocorticoids oppose translational control by leucine in skeletal muscle
Shah, O. J., Anthony, J. C., Kimball, S. R., & Jefferson, L. S. (2000) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.2000.279.5.e1185 · Cited by 73
Effect of the glucocorticoid receptor antagonist RU 38486 on muscle protein breakdown in sepsis.
Hall-Angerås, M., Angerås, U., Zamir, O., Hasselgren, P. O., & Je, F. (1991) · PubMed · Cited by 73
Kawada, S., Tachi, C., & Ishii, N. (2001) · Journal of Muscle Research and Cell Motility · doi:10.1023/a:1016366409691 · Cited by 70
Turnover of skeletal muscle contractile proteins in glucocorticoid myopathy
Seene, T. (1994) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/0960-0760(94)90165-1 · Cited by 56
Glucocorticoid Receptor-Mediated Induction of Glutamine Synthetase in Skeletal Muscle Cellsin Vitro*
Max, S. R., Thomas, J. W., Banner, C., Vitković, L., Konagaya, M., & Konagaya, Y. (1987) · Endocrinology · doi:10.1210/endo-120-3-1179 · Cited by 48
Fang, C., Li, B. G., Tiao, G. M., Wang, J. J., Fischer, J. E., & Hasselgren, P.-O. (1998) · International Journal of Molecular Medicine · doi:10.3892/ijmm.1.1.163 · Cited by 40
Effects of glucocorticoid treatment and food restriction on rat hindlimb muscles
Gardiner, P. F., Montanaro, G., Simpson, D. R., & Edgerton, V. R. (1980) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1980.238.2.e124 · Cited by 33
Control of Muscle Protein Breakdown: Effects of Activity and Nutritional States
Wolfe, R. R. (2001) · International Journal of Sport Nutrition and Exercise Metabolism · doi:10.1123/ijsnem.11.s1.s164 · Cited by 30
Konagaya, M., & Max, S. R. (1986) · Journal of Steroid Biochemistry · doi:10.1016/0022-4731(86)90240-2 · Cited by 28
Glucocorticoid-induced atrophy in different fibre types of selected rat jaw and hind-limb muscles
Roy, R. R., Gardiner, P. F., Simpson, D. R., et al. (1983) · Archives of Oral Biology · doi:10.1016/0003-9969(83)90012-2 · Cited by 23
Quan, Z. Y., & Walser, M. (1991) · Metabolism · doi:10.1016/0026-0495(91)90026-s · Cited by 15
Cited by
The Molecular Basis of Skeletal Muscle Atrophy
Jackman, R. W., & Kandarian, S. C. (2004) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00579.2003 · Cited by 1,008
REGULATION OF MUSCLE MASS BY MYOSTATIN
Lee, S.-J. (2004) · Annual Review of Cell and Developmental Biology · doi:10.1146/annurev.cellbio.20.012103.135836 · Cited by 819
Glucocorticoid-Induced Skeletal Muscle Atrophy
Schakman, O., Kalista, S., Barbé, C., Loumaye, A., & Thissen, J. P. (2013) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2013.05.036 · Cited by 705
Glucocorticoids, metabolism and metabolic diseases
Vegiopoulos, A., & Herzig, S. (2007) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2007.05.015 · Cited by 535
Mechanisms of glucocorticoid-induced myopathy
Schakman, O., Gilson, H., & Thissen, J. P. (2008) · Journal of Endocrinology · doi:10.1677/joe-07-0606 · Cited by 521
Metadata
- Authors
- Ma, K., Mallidis, C., Bhasin, S., Mahabadi, V., Artaza, J., Gonzalez-Cadavid, N., Arias, J., & Salehian, B.
- Venue
- American Journal of Physiology-Endocrinology and Metabolism
- Publisher
- American Physiological Society
- Published
- 2003-08
- Volume
- 285
- Issue
- 2
- Pages
- E363-E371
- ISSN
- 0193-1849 (ISSN-L)
- 1522-1555
- OpenAlex
- W2116082328
- Cited by
- 414
- References
- 44
- FWCI
- 5.25
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.